tiprankstipranks
Trending News
More News >
New Providence Acquisition Corp. III Class A (NPAC)
NASDAQ:NPAC
US Market

Compare New Providence Acquisition Corp. III Class A (NPAC) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
New Providence Acquisition Corp. III Class A
$10.28
$394.27M
-1.15%
Bayview Acquisition Corp Class A
$11.86
$41.11M
295.86
9.76%
Roma Green Finance Limited
$2.33
$135.21M
-16.97
247.76%
FibroBiologics, Inc.
$0.34
$22.63M
-0.70
-83.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Alto Neuroscience, Inc.
$17.02
$533.10M
-7.40
295.81%
9 Buy
0 Hold
0 Sell
Strong Buy
Telomir Pharmaceuticals, Inc.
$1.35
$46.41M
-3.67
-71.69%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NPAC
New Providence Acquisition Corp. III Class A
10.28
-0.07
-0.68%
BAYA
Bayview Acquisition Corp Class A
11.81
1.03
9.51%
ROMA
Roma Green Finance Limited
2.33
1.68
258.46%
FBLG
FibroBiologics, Inc.
0.34
-1.57
-82.36%
ANRO
Alto Neuroscience, Inc.
17.02
12.59
284.20%
TELO
Telomir Pharmaceuticals, Inc.
1.37
-3.42
-71.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts